Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities

A gain in chromosome 1q (+1q) is among the most common cytogenetic abnormalities in multiple myeloma (MM). It is unclear whether +1q is independently associated with decreased overall survival (OS). The objective of this study was to evaluate the impact of +1q on clinical characteristics, treatment...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Principais autores: Abdallah, Nadine, Greipp, Patricia, Kapoor, Prashant, Gertz, Morie A., Dispenzieri, Angela, Baughn, Linda B., Lacy, Martha Q., Hayman, Suzanne R., Buadi, Francis K., Dingli, David, Go, Ronald S., Hwa, Yi L., Fonder, Amie, Hobbs, Miriam, Lin, Yi, Leung, Nelson, Kourelis, Taxiarchis, Warsame, Rahma, Siddiqui, Mustaqeem, Lust, John, Kyle, Robert A., Bergsagel, Leif, Ketterling, Rhett, Rajkumar, S. Vincent, Kumar, Shaji K.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2020
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7422105/
https://ncbi.nlm.nih.gov/pubmed/32750129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002218
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados